{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:10:33Z","timestamp":1790539833339,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"am","delay-in-days":284,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Reims University Hospital"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jchromb.2020.122226","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T21:04:33Z","timestamp":1591650273000},"page":"122226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Quantification of methadone, buprenorphine, naloxone, opioids, and their derivates in whole blood by liquid chromatography-high-resolution mass spectrometry: Analysis of their involvement in fatal forensic cases"],"prefix":"10.1016","volume":"1152","author":[{"given":"Catherine","family":"Feliu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Konecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Binet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Vautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Haudecoeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Oget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Fouley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Marty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Gozalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoann","family":"Cazaubon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoubir","family":"Djerada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2020.122226_b0005","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1056\/NEJMp1710862","article-title":"Emergency legal authority and the opioid crisis","volume":"377","author":"Rutkow","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jchromb.2020.122226_b0010","doi-asserted-by":"crossref","first-page":"557","DOI":"10.5811\/westjem.2018.2.38087","article-title":"The Opioid Crisis in America: Too much, too little, too late","volume":"19","author":"Koenig","year":"2018","journal-title":"West. J. Emerg. Med."},{"key":"10.1016\/j.jchromb.2020.122226_b0015","unstructured":"European Drug Report 2019: Trends and Developments | www.emcdda.europa.eu, (n.d.). http:\/\/www.emcdda.europa.eu\/publications\/edr\/trends-developments\/2019 (accessed June 10, 2019)."},{"key":"10.1016\/j.jchromb.2020.122226_b0020","unstructured":"National Institute on Drug, Overdose Death Rates, 2017. https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates (accessed May 25, 2018)."},{"key":"10.1016\/j.jchromb.2020.122226_b0025","doi-asserted-by":"crossref","unstructured":"P. Mura, P. Kintz, eds., Drogues et accidentalit\u00e9, EDP sciences, DL 2011, Les Ulis, France, 2011.","DOI":"10.3917\/edp.mura.2011.01.0003"},{"key":"10.1016\/j.jchromb.2020.122226_b0030","unstructured":"R.C. Baselt, Disposition of toxic drugs and chemicals in man, Biomedical Publications, Foster City (Calif.), Etats-Unis, 2008."},{"key":"10.1016\/j.jchromb.2020.122226_b0035","first-page":"54","article-title":"Clinical and analytical toxicology of opiate, cocaine and amphetamine","volume":"73","author":"Feliu","year":"2015","journal-title":"Ann. Biol. Clin. (Paris)"},{"key":"10.1016\/j.jchromb.2020.122226_b0040","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.4155\/bio.11.168","article-title":"Novel strategies for sample preparation in forensic toxicology","volume":"3","author":"Samanidou","year":"2011","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2020.122226_b0045","unstructured":"Y. Gaillard, G. Pepin, P. Marquet, P. Kintz, M. Deveaux, P. Mura, Identification and quantification of benzoylecgonine, cocaine, methylecgonine-ester, codeine, morphine and 6-acetylmorphine in whole blood, Toxicorama, 1996."},{"key":"10.1016\/j.jchromb.2020.122226_b0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clinbiochem.2010.08.008","article-title":"Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology","volume":"44","author":"Peters","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jchromb.2020.122226_b0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jpba.2015.12.055","article-title":"Comparison of a triple-quadrupole and a quadrupole time-of-flight mass analyzer to quantify 16 opioids in human plasma","volume":"127","author":"Viaene","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2020.122226_b0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/jat\/bku066","article-title":"Multi-drug and metabolite quantification in postmortem blood by liquid chromatography-high-resolution mass spectrometry: comparison with nominal mass technology","volume":"38","author":"Rosano","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2020.122226_b0065","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.4155\/bio.15.157","article-title":"Validation of a fast UPLC-MS\/MS method for quantitative analysis of opioids, cocaine, amphetamines (and their derivatives) in human whole blood","volume":"7","author":"Feliu","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2020.122226_b0070","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/bmc.1394","article-title":"Quantification of midazolam, morphine and metabolites in plasma using 96-well solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry","volume":"24","author":"Ahsman","year":"2010","journal-title":"Biomed. Chromatogr. BMC"},{"key":"10.1016\/j.jchromb.2020.122226_b0075","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/jat\/31.7.394","article-title":"Method for quantification of opioids and their metabolites in autopsy blood by liquid chromatography-tandem mass spectrometry","volume":"31","author":"Al-Asmari","year":"2007","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2020.122226_b0080","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s00216-009-3268-9","article-title":"Determination of 19 drugs of abuse and metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry","volume":"396","author":"Bj\u00f8rk","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2020.122226_b0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12024-015-9673-9","article-title":"Quantification of morphine, morphine 6-glucuronide, buprenorphine, and the enantiomers of methadone by enantioselective mass spectrometric chromatography in whole blood","volume":"11","author":"Christoffersen","year":"2015","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.jchromb.2020.122226_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jat\/31.1.1","article-title":"Simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, oxycodone, and 6-acetylmorphine in urine, serum, plasma, whole blood, and meconium by LC-MS-MS","volume":"31","author":"Coles","year":"2007","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2020.122226_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2015.06.028","article-title":"Development of a new multi-analyte assay for the simultaneous detection of opioids in serum and other body fluids using liquid chromatography-tandem mass spectrometry","volume":"1001","author":"Eckart","year":"2015","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci."},{"key":"10.1016\/j.jchromb.2020.122226_b0100","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/FTD.0b013e31828e7e6b","article-title":"Quantitative analysis of 26 opioids, cocaine, and their metabolites in human blood by ultra performance liquid chromatography-tandem mass spectrometry","volume":"35","author":"Fernandez","year":"2013","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2020.122226_b0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpba.2015.04.044","volume":"114","author":"Moreno-Vicente","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2020.122226_b0110","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.clinbiochem.2015.05.023","article-title":"The development of a high-performance liquid chromatography-tandem mass spectrometric method for simultaneous quantification of morphine, morphine-3-\u03b2-glucuronide, morphine-6-\u03b2-glucuronide, hydromorphone, and normorphine in serum","volume":"48","author":"Sartori","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jchromb.2020.122226_b0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/chromsci\/40.1.40","article-title":"A rapid and sensitive high-performance liquid chromatography-electrospray ionization-triple quadrupole mass spectrometry method for the quantitation of oxycodone in human plasma","volume":"40","author":"Dawson","year":"2002","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2020.122226_b0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jchromb.2012.07.005","article-title":"High-throughput assay for simultaneous quantification of the plasma concentrations of morphine, fentanyl, midazolam and their major metabolites using automated SPE coupled to LC-MS\/MS","author":"Ghassabian","year":"2012","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci. 903"},{"key":"10.1016\/j.jchromb.2020.122226_b0125","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/FTD.0b013e3181dca295","article-title":"Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology","volume":"32","author":"Maurer","year":"2010","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2020.122226_b0130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.clinbiochem.2010.08.018","article-title":"HPLC-high resolution mass spectrometry in clinical laboratory?","volume":"44","author":"Jiwan","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jchromb.2020.122226_b0135","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/rcm.2429","article-title":"Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography\/time-of-flight mass spectrometry","volume":"20","author":"Ojanper\u00e4","year":"2006","journal-title":"Rapid Commun. Mass Spectrom. RCM"},{"key":"10.1016\/j.jchromb.2020.122226_b0140","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/15563650.2012.713108","article-title":"Role of liquid chromatography-high-resolution mass spectrometry (LC-HR\/MS) in clinical toxicology","volume":"50","author":"Wu","year":"2012","journal-title":"Clin. Toxicol. Phila. Pa"},{"key":"10.1016\/j.jchromb.2020.122226_b0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.chroma.2012.08.069","article-title":"What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening?","volume":"1292","author":"Maurer","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2020.122226_b0150","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.4155\/bio.14.164","article-title":"Current position of high-resolution MS for drug quantification in clinical & forensic toxicology","volume":"6","author":"Meyer","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2020.122226_b0155","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00204-016-1764-1","article-title":"High-resolution mass spectrometry in toxicology: current status and future perspectives","volume":"90","author":"Maurer","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jchromb.2020.122226_b0160","unstructured":"European Medicines Agency (EMA), Guideline on bioanalytical method validation. 21 July 2011. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdf. (accessed June 2013)., (n.d.). http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdf."},{"key":"10.1016\/j.jchromb.2020.122226_b0165","unstructured":"US Food and Drug Administration, Guidance for industry. Bioanalytical method validation; May 2001. http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm070107.pdf. (accessed july 2010), (n.d.). http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm070107.pdf (accessed April 2, 2013)."},{"key":"10.1016\/j.jchromb.2020.122226_b0170","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2020.122226_b0175","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jpba.2013.08.002","article-title":"Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS\/MS technology","volume":"86","author":"Djerada","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2020.122226_b0180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.forsciint.2014.03.008","article-title":"Long-term stability of morphine, codeine, and 6-acetylmorphine in real-life whole blood samples, stored at -20\u00b0C","volume":"239","author":"H\u00f8iseth","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jchromb.2020.122226_b0185","doi-asserted-by":"crossref","DOI":"10.1093\/jat\/bku080","article-title":"Long-term storage of authentic postmortem forensic blood samples at -20\u00b0C: measured concentrations of benzodiazepines, central stimulants, opioids and certain medicinal drugs before and after storage for 16\u201318 Years","author":"Karinen","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2020.122226_b0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.forsciint.2004.02.013","article-title":"Postmortem toxicology of drugs of abuse","volume":"142","author":"Drummer","year":"2004","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jchromb.2020.122226_b0195","unstructured":"A. Makarov, Mass spectrometer; 1999 US Patent, 5886346, n.d."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023219318732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023219318732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:02:49Z","timestamp":1761606169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023219318732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":39,"alternative-id":["S1570023219318732"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122226","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of methadone, buprenorphine, naloxone, opioids, and their derivates in whole blood by liquid chromatography-high-resolution mass spectrometry: Analysis of their involvement in fatal forensic cases","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122226"}}